Company Tagline
Developing Innovative Cell Therapies Against Cancer
Industry Category
Business Keywords
Company Description
Celyad Oncology is a pioneering biotechnology company focused on the discovery and advancement of innovative chimeric antigen receptor (CAR) T-cell technologies. With a commitment to unlocking the full potential of proprietary technology platforms and intellectual property, Celyad Oncology is dedicated to developing next-generation CAR T-cell therapies. The company strives to maximize the transformative impact of its candidate CAR T-cell therapies, aiming to redefine the future of cancer treatment. Celyad Oncology's primary address is located at 9 rue André Dumont, Mont-Saint-Guibert, 1435, BE.
Celyad Oncology is at the forefront of the immuno-oncology field, leveraging its expertise to create groundbreaking therapies. By continuously pushing the boundaries of scientific innovation, Celyad Oncology is committed to improving patient outcomes and making a significant impact on the lives of individuals affected by cancer. The company's research and development efforts are geared towards developing novel approaches to combat cancer and providing hope for patients in need.
Celyad Oncology is poised to make significant contributions to the future of cancer treatment. The company welcomes you to explore potential collaborations and discover how its advanced CAR T-cell therapies can drive progress in oncology. We invite the manager of Celyad Oncology to create a customized and exclusive company showcase and product listing on our platform, enhancing visibility and fostering new partnerships.
Celyad Oncology est une entreprise de biotechnologie pionnière axée sur la découverte et l'avancement de technologies innovantes de récepteurs d'antigènes chimériques (CAR) des cellules T. Avec un engagement à libérer tout le potentiel des plateformes technologiques propriétaires et de la propriété intellectuelle, Celyad Oncology se consacre au développement de thérapies CAR-T cellulaires de nouvelle génération. L'entreprise s'efforce de maximiser l'impact transformateur de ses thérapies CAR-T cellulaires candidates, dans le but de redéfinir l'avenir du traitement du cancer. L'adresse principale de Celyad Oncology est située au 9 rue André Dumont, Mont-Saint-Guibert, 1435, BE.
Celyad Oncology est à l'avant-garde du domaine de l'immuno-oncologie, tirant parti de son expertise pour créer des thérapies révolutionnaires. En repoussant continuellement les limites de l'innovation scientifique, Celyad Oncology s'engage à améliorer les résultats pour les patients et à avoir un impact significatif sur la vie des personnes touchées par le cancer. Les efforts de recherche et développement de l'entreprise sont axés sur le développement de nouvelles approches pour lutter contre le cancer et donner de l'espoir aux patients dans le besoin.
Celyad Oncology est sur le point d'apporter une contribution significative à l'avenir du traitement du cancer. L'entreprise vous invite à explorer des collaborations potentielles et à découvrir comment ses thérapies CAR-T cellulaires avancées peuvent faire progresser l'oncologie. Nous invitons le responsable de Celyad Oncology à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, améliorant ainsi la visibilité et favorisant de nouveaux partenariats.
Key Personnel / Employees
Compare Companies Side by Side
Compare Celyad Oncology with 3 companies in Biotechnology-Research
| Comparison Field |
Celyad OncologyMain Company |
MolecureView Profile |
HOOKIPA Pharma Inc.View Profile |
Oncimmune - An Alden...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2012 | 2011 | 2006 |
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
Warsaw, Mazowieckie | New York, New York | Cambridge, MA | |
|
Country
|
Poland | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
CAR T-cell therapy
Immuno-oncology
Biotechnology
Cancer research
Cell therapy
Immunotherapy
Oncology
shRNA multiplex
Cancer
NKG2D
Immuno-Oncology
CAR T-cells
|
11 Total
1 Common
10 Unique
Match
8%
Common Skills:
Immuno-oncology
Unique Skills:
arginase
chitinase
fibrotic diseases
inflammatory diseases
Medicinal chemistry
+4
|
1 Total
1 Unique
Unique Skills:
Infectious diseases
|
10 Total
10 Unique
Unique Skills:
Autoantibodies
Autoimmune Disease
Bioinformatics
Companion diagnostics
COVID-19
Immuno oncology
+4
|
4
Total Companies2006
Oldest Founded2
Countries33
Unique SkillsSimilar Companies
Other organizations in the same industry
TFChem
Biotechnology-ResearchDevelop innovative actives for tomorrow’s Drugs and Cosmetics
Ascension Sciences
Biotechnology-ResearchNano Solutions, Macro Possibilities | Advanced nanoparticle formulation for nutraceuticals and pharm...
Tisento Therapeutics
Biotechnology-ResearchTo those lacking effective treatment options: We hear you. And we are relentlessly driving toward mu...
Confidence Analytics®
Biotechnology-ResearchCannabis. Certified.
Alternative Company Names
This company is also known as